Cynosure Lutronic reports 3x faster treatment cycles for XERF, driving rapid clinic adoption and changing device ROI calculations.
Cynosure Lutronic's XERF radiofrequency platform is seeing accelerated worldwide adoption, with the company reporting that the device now operates 3x faster than prior generations. XERF is a monopolar RF device cleared for skin tightening and collagen remodeling—a core offering in the energy-device market alongside fractional CO2, erbium, and microneedling RF.
The speed advantage is operationally critical. Faster treatment cycles directly improve patient throughput and device ROI. A practice can treat more patients per day, reducing the per-procedure cost allocation and improving break-even patient volume. This is particularly relevant for high-volume aesthetic practices where device utilization drives profitability.
3x faster treatment cycles reshape device ROI and patient throughput economics.
XERF competes with InMode's Morpheus8 RF microneedling and traditional monopolar RF systems. The adoption velocity suggests practices are prioritizing treatment speed and efficiency—a signal that device economics (not just clinical outcomes) are driving purchasing decisions. For owners evaluating RF modalities, the throughput data should factor heavily into your acquisition and leasing analysis.
Source: original report ↗
Frequently asked questions
How much faster is XERF radiofrequency compared to older RF devices?
XERF operates 3x faster than prior-generation radiofrequency devices, significantly reducing treatment cycle time. This speed advantage directly improves patient throughput and allows practices to treat more patients per day, lowering per-procedure cost allocation.
Does faster RF treatment speed affect device ROI for med spas?
Yes. Faster treatment cycles reduce break-even patient volume and improve device profitability by increasing daily patient capacity. For high-volume aesthetic practices, treatment speed is now a primary driver of device economics and return on investment.
What is XERF radiofrequency cleared to treat?
XERF is a monopolar RF device cleared for skin tightening and collagen remodeling. It competes with RF microneedling systems like Morpheus8 and traditional monopolar RF platforms in the energy-device market.
Should med spa owners prioritize treatment speed when buying RF devices?
Yes. The rapid adoption of XERF indicates that practices are prioritizing treatment speed and efficiency alongside clinical outcomes when making device purchasing decisions. Speed directly impacts throughput, cost per procedure, and overall device profitability.
How does XERF compare to Morpheus8 RF microneedling?
XERF is a monopolar RF system, while Morpheus8 is an RF microneedling device—different modalities serving overlapping clinical needs. XERF's 3x speed advantage and monopolar approach appeal to practices focused on maximizing patient throughput and device utilization.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
